Within the cord blood industry, there was a robust growth period during the mid-to-late 2000s. However, over the past several years, the market has matured and consolidated. While strong industry growth has continued within North Asia (particularly within China, Hong Kong, and Taiwan) and Southeast Asia (led by India and Malaysia), growth within the North American and European markets has not been as robust.